Naba Al Saha Medical Services Company (TADAWUL:9546)
Saudi Arabia · Delayed Price · Currency is SAR 23.20
+0.21 (0.91%)
Sep 3, 2026, 12:06 PM AST
TADAWUL:9546 Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 206.15 | 201.81 | 194.28 | 182.35 | 129.68 | 117.68 |
Revenue Growth | 2.15% | 3.88% | 6.54% | 40.61% | 10.20% | 1.73% |
Gross Profit Gross Profit Growth | 67.66 | 63.33 | 60 | 71.78 | 49.88 | 45.36 |
Operating Income Operating Income Growth | 32.8 | 32.36 | 25.27 | 43.84 | 29.81 | 27.82 |
Net Income Net Income Growth | 28.55 | 27.53 | 21.78 | 52.38 | 26.92 | 25.83 |
Earnings Per Share EPS Growth | 1.09 | 1.31 | 1.04 | 2.49 | 1.28 | 1.23 |
EPS Growth | -16.78% | 26.37% | -58.41% | 94.57% | 4.24% | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Services Medical Services Growth | 188.85 | 181.6 | 170.39 | 118.86 | 108.56 |
Pharmaceuticals Pharmaceuticals Growth | 12.97 | 12.69 | 11.97 | 10.82 | 9.12 |
Total Total Growth | 201.81 | 194.28 | 182.35 | 129.68 | 117.68 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | - | 18.99 | 42.78 | 5.75 | 13.83 | 6.99 |
Total Debt Total Debt Growth | - | 122.81 | 89.17 | 48.19 | 22.07 | 33.29 |
Net Cash (Debt) Net Cash Growth | - | -103.82 | -46.39 | -42.45 | -8.24 | -26.3 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | - | -4.94 | -2.21 | -2.02 | -0.39 | -1.25 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 22.85 | 26.79 | 35.64 | 29.36 | 35.5 | 30.74 |
Capital Expenditures CapEx Growth | -70.02 | -70.02 | -37.46 | -38.87 | -7.55 | -10.36 |
Free Cash Flow Free Cash Flow Growth | -47.17 | -43.23 | -1.83 | -9.51 | 27.95 | 20.37 |
Free Cash Flow Growth | - | - | - | - | 37.19% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.82% | 31.38% | 30.88% | 39.36% | 38.46% | 38.55% |
Operating Margin | 15.91% | 16.04% | 13.00% | 24.04% | 22.98% | 23.64% |
Pretax Margin | 15.07% | 15.18% | 12.90% | 30.09% | 22.31% | 23.39% |
Profit Margin | 13.85% | 13.64% | 11.21% | 28.73% | 20.76% | 21.95% |
FCF Margin | -22.88% | -21.42% | -0.94% | -5.21% | 21.55% | 17.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.150 | - | 0.150 | - | 0.100 | 0.100 |
Dividend Per Share Growth | - | - | - | - | 0% | - |
Dividend Yield | 0.65% | - | 0.38% | - | 0.70% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.07 | 18.69 | 38.08 | 12.03 | 11.18 | - |
P/FCF Ratio | - | - | - | - | 10.77 | - |
PS Ratio | 2.36 | 2.55 | 4.27 | 3.46 | 2.32 | - |